Seoul St.Mary's Hospital
Seoul, Seocho-gu, 07651, South Korea
NCT Number: NCT04840511
This study will be done to investigate perioperative lidocaine infusion on neutrophil extracellular trapping in the patients undergoing the robot-assisted prostatectomy.
This study is active but is not currently recruiting participants.
20 year–75 year
Male
Interventional
Not applicable
Seoul, Seocho-gu, 07651, South Korea
Neutrophil extracellular trapping by analyzing the meyloperoxidase, neutrophil elastase, citrullinated histone3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
lidocaine 1.5 mg/kg bolus (infused over 10 min) followed by 2.0 mg/kg/h during operation and 1.0 mg/kg/h during postoperative 24 hours (no more than 120 mg/h)
Other names: lidocaine
normal saline 0.15 ml bolus followed by 0.2 ml/kg/hr during operation and 0.1 ml/kg/hr during postoperative 24 hours
Other names: normal saline
Time frame: 24 hours after surgery
This will be obtained using ELISA.
Time frame: 24 hours after surgery
This will be obtained using ELISA.
Time frame: 24 hours after surgery
This will be obtained using ELISA.
Time frame: during postoperative 24 hours
This will be measured using NRS (numeric rating scale; 0=no pain, 10=the worst pain)
The Catholic University of Korea
Other
The Effect of Perioperative Lidocaine Infusion on Neutrophil Extracellular Trapping in the Patients Undergoing the Robot-assisted Prostatectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06111235
Bladder Cancer, Carcinoma
Homewood, Alabama, United States
View Trial DetailsNCT05725304
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Taipei, Taiwan
View Trial DetailsNCT07216456
Anorectal Cancer, Female Urogenital Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07634666
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Seoul, South Korea
View Trial Details